A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape
Viruses · 2023
DOI: 10.3390/v15040838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Felix Lehmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF;…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), German Ministry of Health via the Robert Koch Institute, Berlin.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection is a global health threat. Mutations in the surface antigen of HBV (HBsAg) may alter its antigenicity, infectivity, and transmissibility. A patient positive for HBV DNA and detectable but low-level HBsAg in parallel with anti-HBs suggested the presence of immune and/or diagnostic escape variants. To support this hypothesis, serum-derived HBs gene sequences were amplified and cloned for sequencing, which revealed infection with exclusively non-wildtype HBV subgenotype (sgt) D3. Three distinct mutations in the antigenic loop of HBsAg that caused additional N-glycosylation were found in the variant sequences, including a previously undescribed six-nucleotide insertion. Cellular and secreted HBsAg was analyzed for N-glycosylation in Western blot after expression in human hepatoma cells. Secreted HBsAg was also subjected to four widely used, state-of-the-art diagnostic assays, which all failed to detect the hyperglycosylated insertion variant. Additionally, the recognition of mutant HBsAg by vaccine- and natural infection-induced anti-HBs antibodies was severely impaired. Taken together, these data suggest that the novel six-nucleotide insertion as well as two other previously described mutations causing hyperglycosylation in combination with immune escape mutations have a critical impact on in vitro diagnostics and likely increase the risk of breakthrough infection by evasion of vaccine-induced immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF; Partner Site Giessen-Marburg-Langen), Justus Liebig University, 35392…
- Department of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.
- Department of Medicine B, University Hospital Muenster, 48149 Muenster, Germany.
- Department of Gastroenterology, Medical Center Osnabrueck, 49076 Osnabrueck, Germany.
ORCID-Profile: Felix Lehmann, Heiko Slanina, Martin Roderfeld, Elke Roeb, Jonel Trebicka, John Ziebuhr, Dieter Glebe
Förderung
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
- German Ministry of Health via the Robert Koch Institute, Berlin
Zitieren
APA
Lehmann, F., Slanina, H., Roderfeld, M., Roeb, E., Trebicka, J., Ziebuhr, J., Gerlich, W. H., Schüttler, C. G., Schlevogt, B., & Glebe, D. (2023). A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape. Viruses. https://doi.org/10.3390/v15040838
Vancouver
Lehmann F, Slanina H, Roderfeld M, Roeb E, Trebicka J, Ziebuhr J, et al. A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape. Viruses. 2023. doi:10.3390/v15040838
BibTeX
@article{Lehmann2023,
author = {Lehmann, Felix and Slanina, Heiko and Roderfeld, Martin and Roeb, Elke and Trebicka, Jonel and Ziebuhr, John and Gerlich, Wolfram H and Schüttler, Christian G and Schlevogt, Bernhard and Glebe, Dieter},
title = {A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040838}
}
EUVIMED